AMPH – Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals, Inc.

AMPH

$31.28

Name : Amphastar Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $1,503,986,176.00

EPSttm : 3.01

Amphastar Pharmaceuticals, Inc.

$31.28

0.06%

$0.02

Float Short %

11.42

Margin Of Safety %

Put/Call OI Ratio

0.41

EPS Next Q Diff

-0.08

EPS Last/This Y

EPS This/Next Y

-0.22

Price

31.24

Target Price

44.4

Analyst Recom

Performance Q

-29.17

Relative Volume

0.92

Beta

0.73

Ticker: AMPH

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-23	AMPH	36.4	0.45	0.00	866
2025-01-24	AMPH	36.51	0.44	4.33	876
2025-01-27	AMPH	37.15	0.44	0.06	881
2025-01-28	AMPH	37.14	0.40	0.10	940
2025-01-29	AMPH	36.43	0.41	3.00	932
2025-01-30	AMPH	36.36	0.41	2.00	932
2025-01-31	AMPH	34.86	0.41	1.41	933
2025-02-03	AMPH	33.39	0.44	0.36	985
2025-02-04	AMPH	32.99	0.43	1.00	985
2025-02-05	AMPH	32.8	0.43	1.25	989
2025-02-06	AMPH	32.77	0.42	0.02	993
2025-02-07	AMPH	32.35	0.42	1.09	1003
2025-02-10	AMPH	32.21	0.43	4.33	1025
2025-02-11	AMPH	32.19	0.46	0.00	1067
2025-02-12	AMPH	31.81	0.46	0.00	1077
2025-02-13	AMPH	31.71	0.45	0.09	1081
2025-02-14	AMPH	31	0.46	2.50	1083
2025-02-18	AMPH	30.74	0.46	0.16	1087
2025-02-19	AMPH	31.17	0.46	0.22	1094
2025-02-20	AMPH	31.33	0.46	0.33	1119
2025-02-21	AMPH	31.26	0.41	7.75	1084
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-23	AMPH	36.39	10.8	-	3.89
2025-01-24	AMPH	36.53	10.8	-	3.89
2025-01-27	AMPH	37.14	10.8	-	3.89
2025-01-28	AMPH	37.13	10.8	-	3.89
2025-01-29	AMPH	36.41	10.8	-	3.89
2025-01-30	AMPH	36.37	8.8	-	3.89
2025-01-31	AMPH	34.85	8.8	-	3.89
2025-02-03	AMPH	33.39	8.8	-	3.89
2025-02-04	AMPH	33.19	8.8	-	3.89
2025-02-05	AMPH	32.81	8.8	-	3.89
2025-02-06	AMPH	32.78	8.8	-	3.89
2025-02-07	AMPH	32.36	8.8	-	3.89
2025-02-10	AMPH	32.21	8.8	-	3.89
2025-02-11	AMPH	32.24	8.8	-	3.89
2025-02-12	AMPH	31.82	8.8	-	3.89
2025-02-13	AMPH	31.72	8.8	-	3.89
2025-02-14	AMPH	31.02	8.8	-	3.89
2025-02-18	AMPH	30.75	6.6	-	3.89
2025-02-19	AMPH	31.21	6.6	-	3.89
2025-02-20	AMPH	31.29	6.6	-	3.89
2025-02-21	AMPH	31.24	6.6	-	3.89
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-23	AMPH	-0.70	2.20	13.45
2025-01-24	AMPH	-0.70	2.20	13.45
2025-01-27	AMPH	-0.70	1.91	13.45
2025-01-28	AMPH	-0.70	1.91	12.85
2025-01-29	AMPH	-0.70	1.91	12.85
2025-01-30	AMPH	-0.70	1.91	12.85
2025-01-31	AMPH	-0.70	1.91	12.85
2025-02-03	AMPH	-0.62	4.98	12.85
2025-02-04	AMPH	-0.62	4.98	12.85
2025-02-05	AMPH	-0.62	4.98	12.85
2025-02-06	AMPH	-0.62	4.98	12.85
2025-02-07	AMPH	-0.62	4.98	12.85
2025-02-10	AMPH	-0.62	5.05	12.89
2025-02-11	AMPH	-0.62	5.05	12.89
2025-02-12	AMPH	-0.62	5.05	11.54
2025-02-13	AMPH	-0.62	5.05	11.54
2025-02-14	AMPH	-0.49	5.05	11.42
2025-02-18	AMPH	-0.49	5.49	11.42
2025-02-19	AMPH	-0.49	5.49	11.42
2025-02-20	AMPH	-0.49	5.49	11.42
2025-02-21	AMPH	-0.49	5.49	11.42
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.96

Avg. EPS Est. Current Quarter

0.97

Avg. EPS Est. Next Quarter

0.88

Insider Transactions

-0.49

Institutional Transactions

5.49

Beta

0.73

Average Sales Estimate Current Quarter

192

Average Sales Estimate Next Quarter

177

Fair Value

45.09

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

53.8

Max Drawdown 5-Year %

-52.7

Target Price

44.4

P/E

10.41

Forward P/E

8.53

PEG

1.32

P/S

2.08

P/B

2.08

P/Free Cash Flow

8.84

EPS

3.01

Average EPS Est. Cur. Y

3.89

EPS Next Y. (Est.)

3.67

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

21.8

Relative Volume

0.92

Return on Equity vs Sector %

2.4

Return on Equity vs Industry %

13.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

Amphastar Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 1761

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company provides Amphadase, an injection to absorb and disperse other injected drugs; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

stock quote shares AMPH – Amphastar Pharmaceuticals Inc Stock Price stock today

news today AMPH – Amphastar Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch AMPH – Amphastar Pharmaceuticals Inc yahoo finance google finance

stock history AMPH – Amphastar Pharmaceuticals Inc invest stock market

stock prices AMPH premarket after hours

ticker AMPH fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

AMPH – Amphastar Pharmaceuticals Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: AMPH

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y